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NortriptylineTreatment of major depression, posttraumatic stress disorder and other psychopathologies with antidepres-
sants can be associated with improvement of the cognitive deﬁcits related to these disorders. Although the
mechanisms of these effects are not completely elucidated, alterations in the extinction of aversive memories
are believed to play a role in these psychopathologies. We have recently veriﬁed that female rats present low
levels of extinction when submitted to the plus-maze discriminative avoidance task. In the present study,
female rats were treated long term with clinically used antidepressants (ﬂuoxetine, nortriptyline or mirtaza-
pine) and subjected to the plus-maze discriminative avoidance task to evaluate learning, memory, extinction
and anxiety-related behaviors as well as behavioral despair in the forced swimming test. All groups learned
the task and exhibited retrieval. Chronic treatment with ﬂuoxetine (but not with the other antidepressants
tested) increased extinction of the discriminative task. In the forced swimming test, the animals treated
with ﬂuoxetine and mirtazapine showed decreased immobility duration. In conclusion, ﬂuoxetine poten-
tiated extinction, while both ﬂuoxetine and mirtazapine were effective in ameliorating depressive-like
behavior in the forced swimming test, suggesting a possible dissociation between the effects on mood and
the extinction of aversive memories in female rats.
© 2012 Elsevier Inc.Open access under the Elsevier OA license. 1. Introduction
Psychopathological conditions, such as mood and anxiety disorders,
are frequently related to aversive emotional experiences (APA, 2000),
and the reframing of the aversive memory is believed to be beneﬁcial
(Friedman, 2008). It has also been suggested that the cognitive deﬁcits
presented in these disorders are reversed by treatment with antide-
pressants (Austin et al., 2001; Castaneda et al., 2008), which are largely
indicated for both anxiety and mood disorders (Brunello et al., 2001;
Marks et al., 1998; Nandam et al., 2007). Several studies indicate that
the improvement of these cognitive deﬁcits is associated with hippo-
campal neurogenesis (Dranovsky and Hen, 2006; Duman and
Monteggia, 2006; Nandam et al., 2007; Paizanis et al., 2007; Pittenger
and Duman, 2008; Sahay and Hen, 2007; Santarelli et al., 2003). Despite
memory deﬁcits being common in many anxiety- and depression-
related disorders, the relationship between the improvement ofidance task; FST, forced swim-
, aversive enclosed arm; NAV,
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f entries into the open arms;
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.
vier OA license. mood-related symptoms by antidepressants and their effects on
memory remain to be elucidated (Austin et al., 2001).
Several animal studies have investigated the effects of antidepres-
sants on memory (Austin et al., 2001; Castaneda et al., 2008;
MacQueen et al., 2003; Marks et al., 1998; Nestler et al., 2002;
Paizanis et al., 2007; Schulz et al., 2007). However, few studies have
examined the effects of antidepressants speciﬁcally on the extinction
of aversive memories. For example, previous studies in rats have
investigated the effects of rolipram, which has both antidepressant
and anxiolytic effects, on extinction. In these studies, decrements in
extinction of conditioned fear and fear-potentiated startle paradigms
were shown (Monti et al., 2006; Mueller et al., 2010). On the other
hand, this drug has also impaired extinction of a passive avoidance
task (Cheng et al., 2010). In another study, D-cycloserine, an adjuvant
in antidepressant therapy, enhanced extinction in a conditioned fear
task (Yamamoto et al., 2008).
We have recently veriﬁed that female rats present low levels of
extinction when submitted to an aversively motivated task (Ribeiro
et al., 2010). It was suggested that a diminished capacity for extinc-
tion of aversive memories could be related to the predominance of
certain psychopathological disorders, including mood disorders, in
females in general (Curtis, 2005; McLean and Anderson, 2009;
Parker and Brotchie, 2010; Scott, 2011). In the present study, we
investigated if the extinction of this aversive task would be improved
after treatment with clinically effective antidepressants.
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cal groups (ﬂuoxetine, nortriptyline and mirtazapine) on learning,
memory and extinction of the plus-maze discriminative avoidance
task (PMDAT) in female rats were determined. Fluoxetine is a selec-
tive serotonin reuptake inhibitor (SSRI), which is the most frequently
prescribed class of antidepressants (Dunlop and Davis, 2008).
Nortriptyline is a tricyclic antidepressant that acts by nonselective
inhibition of monoaminergic reuptake. Although these compounds
are no longer largely prescribed, they are still an option for individ-
uals who are non-responsive to other antidepressants and for
patients susceptible to serotonin syndrome (Dagtekin et al., 2011).
Finally, the atypical antidepressant mirtazapine is used to treat both
mood and anxiety disorders (Gambi et al., 2005; Rauggi et al., 2005)
and enhances central noradrenergic and serotonergic neurotransmis-
sion through inhibition of the noradrenergic α2-autoreceptor and the
α2-heteroreceptor in serotonergic synapses (Bengtsson et al., 2000;
Gambi et al., 2005).
The PMDAT allows the concomitant evaluation of memory and
anxiety-related behavior. Several studies performed with this task
have shown its effectiveness in evaluating the effects of (1) memory-
enhancing or amnestic drugs, (2) anxiolytic or anxiogenic procedures
and (3) variations in locomotor activity (Silva and Frussa-Filho, 2000;
Silva et al., 1997, 2002a,b). This paradigm is also useful for the evalua-
tion of learning and extinction processes by the analysis of animal
behavior during the training and test sessions, respectively (Ribeiro
et al., 2010; Silva et al., 2004, see Methods). Additionally, the rats
were also assessed using the forced swimming test (FST), a classical
tool used to evaluate the effects of antidepressants (Porsolt et al.,
1977, 1978).
2. Materials and methods
2.1. Animals
Three-month-old female Wistar rats (120–230 g) from our colony
were housed in groups of 4–5 animals in plastic cages (30×
37×16 cm) in a room with acoustic isolation and airﬂow as well as
controlled temperature (24–26 °C), humidity and luminosity (12 h
light:12 h dark, lights on 6:30 a.m.). Food and water were available
ad libitum throughout the experiments. The rats were handled
according to Brazilian law for the use of animals in scientiﬁc research
(Law Number 11.794), and all procedures described here were
approved by the local ethics committee (CEUA-UFRN). All efforts
were made to minimize animal pain, suffering or discomfort as well
as the number of animals used.
2.2. Treatment and general procedures
Animals were allocated to one of the following treatment groups
(n=8–10): (a) ﬂuoxetine (20 mg/ml/kg daily; Medley, Brazil),
(b) nortriptyline (20 mg/ml/kg daily; Novartis, Brazil), (c) mirtazapine
(10 mg/ml/kg daily; Torrent, India), or (d) vehicle (physiological saline
with Tween 20). All treatments were injected intraperitoneally once a
day (from6:00 to 6:30 p.m.) for 19 days. All drugswere diluted in phys-
iological saline containing three drops of Tween 20 per 1 ml.
The duration of treatments and doses were chosen based on
previous studies that demonstrated the efﬁcacy of these antidepres-
sants in rodents submitted to the FST. In these studies, treatment
lengths varied from a single dose to repeated daily doses for
4 weeks, and the effective dose ranges were 5 to 30 mg/kg for ﬂuox-
etine (Carr et al., 2011; Cryan and Lucki, 2000; Djordjevic et al., 2012;
Dulawa et al., 2004; Iñiguez et al., 2010; Miyamoto et al., 2010; Wang
et al., 2011), 20 to 25 mg/kg for nortriptyline (Consoni et al., 2006;
Mallei et al., 2011; Petersén et al., 2009), and 2.5 to 10 mg/kg for
mirtazapine (Nowakowska et al., 1999; Rogóż, 2010; Szymańska
et al., 2009).Throughout the pharmacological treatment and behavioral exper-
iments, the estrous cycle was monitored daily by vaginal smears.
Immediately after injection or behavioral session, plastic pipettes
were gently introduced in the vagina with distillated water (approx-
imately 0.1 ml). Slight, brief pressure was applied to the bulb of the
pipette to collect vaginal cells. The material collected was stained
with methylene blue (5 mg/ml) and analyzed by optical microscope.
All animals included in the study were cycling normally. No estrous
cycle stage predominated among the experimental groups at the
time of testing (2 to 3 animals per stage in each experimental group).
On the 17th day of treatment, the animals were submitted to a
PMDAT training session, and a test session was held 24 h later (on
the 18th day of treatment). On the 19th day of treatment, the animals
were submitted to the ﬁrst session of the FST. The second session was
performed 24 h later. The behavioral tests were performed in such
an order because the stressful nature of the FST can interfere with
the other behavioral evaluations. All behavioral tests were started
at 1:00 p.m., and injections and cycle monitoring were completed at
6:00 p.m. after the behavioral assessments.
2.3. Plus-maze discriminative avoidance task (PMDAT)
The apparatus employed for the PMDAT is a modiﬁed elevated
wood plus-maze containing two enclosed arms (50×15×40 cm) op-
posite two open arms (50×15 cm). In the 10-minute training session,
each rat was placed in the center of the apparatus, and every time the
animal entered the aversive enclosed arm, the rat encountered an
aversive situation that lasted until the animal left the arm. The aver-
sive stimuli included a 100 W light (1500 lx at the maze ﬂoor level)
and an 80 dB noise applied through a speaker placed over the aver-
sive enclosed arm. In the test/extinction session held 24 h later, the
rats were again placed in the apparatus for 10 min without receiving
the aversive stimulation. The lamp and the speaker were still present
over the aversive arm but were in the off position. Several studies
performed with this behavioral model have demonstrated that the
aversive stimuli used are effective. Indeed, when exposed to these
stimuli in a certain arm of the maze, the animals progressively
avoid the speciﬁc arm during a behavioral session (Munguba et al.,
2011; Patti et al., 2006; Ribeiro et al., 2010, 2011; Silva et al., 2004).
Learning was evaluated by the percentage of time spent in the
aversive enclosed arm (time spent in aversive enclosed arm/time
spent in both enclosed arms) during the training session. Retrieval
of the task was evaluated by the comparison of the time spent in
the aversive (AV) and the non-aversive enclosed arms (NAV) in
each group, while extinction of the task was assessed by the percent-
age of time in the aversive arm (%TAV) during the test session. Both
classical (percentage of time spent in open arms, %TOA: time spent
in open arms/time spent in both open and enclosed arms; percent
age of entries into the open arms, %EOA: entries into open arms/en-
tries into both open and enclosed arms) and non-classical anxiety-
related measures (risk assessment and head dipping) were regis-
tered. The risk assessment behavior was deﬁned by body stretching
to look into the open arms of the apparatus before entering (or
not). The head dipping was characterized by an attempt to look
“under” the maze with the head pointing towards the ﬂoor. Increases
in head dipping indicate less anxious behavior (Rodgers and Dalvi,
1997; Rodgers et al., 1997). Locomotor activity was evaluated by the
distance traveled within the apparatus. The behavior of the animals
was monitored and analyzed using the video-tracking software
Anymaze (Stoelting, USA).
2.4. Forced Swimming Test (FST)
In this test rats were placed in a cylinder (40 cm high×25 cm
wide) with water (30 cm deep, 24–27 °C), for two consecutive days.
On the ﬁrst day, the animals were submitted to 15 min of forced
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session, rats were again placed in the water tank (test session) for
5 min, and immobility duration, climbing behavior and the latency
to engage in immobility were registered.
2.5. Statistical analyses
The Kolmogorov–Smirnov test of normality was applied to all
data, and an overall normal distribution was observed. One-way
analysis of variance (ANOVA) with treatment as the between subject
factor and arm type as the within subject factor was applied for the
time spent in the enclosed arms for the total length of each behavioral
session. When arm type effects were detected, pair-wise comparisons
between time spent in AV and time spent in NAV arms were per-
formed using the paired-samples Student t-test. In addition to the
total length of the sessions in the PMDAT, behavioral sessions were
divided into 5 blocks of 2 min each. Comparisons of the percentage
of time in the aversive arm among these blocks within a session
were used to evaluate learning (training) or extinction (test) of the
task and were conducted by ANOVA with repeated measures (blocks
across the session). When time (session blocks) effects were
detected, the paired-samples t-test was used for pair-wise compari-
sons within sessions. Data from other behavioral parameters were
analyzed with one-way ANOVA with Bonferroni's tests for post-hoc
comparisons. Differences were considered signiﬁcant at pb0.05
except when corrections for multiple t-tests comparisons were
applied and the signiﬁcance level was set at pb0.01.
3. Results
3.1. Plus-maze discriminative avoidance task: memory
In the training session, only a signiﬁcant effect for arm type (NAV
vs. AV) was found [F(1,31)=236.68, pb0.001]. The paired-samples0
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Fig. 1.Mean+S.E. of time (s) spent in aversive (Av) and non-aversive (NAv) enclosed arms
(B,D) in the training (A, B) and test (C, D) sessions of female rats repeatedly treated with v
mirtazapine (mirt). (A) and (C): *pb0.01 compared to time in non-aversive arm (Two-wa
effects of time, treatment and time×treatment interaction (ANOVA with repeated measures
to all other groups in the same block (ANOVA and Bonferroni post hoc).t-tests revealed that all groups spent less time in the aversive
enclosed arm in comparison with the non-aversive enclosed arm
[vehicle (t=7.23, pb0.001), ﬂuoxetine (t=9.21, pb0.001), nortrip-
tyline (t=7.63, pb0.001) and mirtazapine (t=7.36, pb0.001)]
(Fig. 1A). This result was conﬁrmed by the analysis of the percentage
of time in the aversive arm across the training session that revealed
time (2-minute session blocks) [F(4,124)=20.80, pb0.001] but not
treatment [F(3,31)=0.73, p=0.54] or time×treatment interaction
effects [F(12,124)=1.34, p=0.22], indicating that all the groups
had learned the task (Fig. 1B).
In the test session, once again, only a signiﬁcant effect for arm type
(NAV vs. AV) was found [F(1,31)=99.42, pb0.001]. The paired-
samples t-tests showed that all groups spent more time in the non-
aversive enclosed arm [vehicle (t=9.08, pb0.001), ﬂuoxetine
(t=4.09, p=0.003), nortriptyline (t=3.86, p=0.008) and mirtaza-
pine (t=4.54, p=0.003)] (Fig. 1C). This result indicates that all the
groups presented similar behaviors in the test session. However, the
analysis of the percentage of time spent in the aversive arm through-
out the test session revealed time [F(4,124)=3.90, p=0.01], treat-
ment [F(12,124)=3.48, p=0.02] and time×treatment interaction
[F(3,31)=2.08, p=0.04] effects (Fig. 1D). Pair-wise comparisons
between the block 1 and all other blocks (2 to 5) showed that the
vehicle-treated animals presented signiﬁcant increases in aversive
arm exploration only in block 5 (t=3.74, p=0.005), indicating
extinction of the task only by the end of the session. On the other
hand, this increase in aversive arm exploration was found earlier
in the session for the ﬂuoxetine-treated group (Block 3, t=3.22,
p=0.01 and block 5, t=3.28, p=0.01). Conversely, the
nortriptyline- and mirtazapine-treated animals did not modify aver-
sive arm exploration across the sessions, indicating the absence of
extinction. Additionally, as a signiﬁcant effect of treatment was
found across the sessions, separate ANOVAs were conducted for
each session block. A signiﬁcant effect of treatment was found in
the block 3 [F(3,31)=7.77, p=0.001], and Bonferroni's post-hoc0
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Table 1
Mean±S.E. for time (s) spent in head dipping and risk assessment behavior in the
training and test sessions presented by female rats repeatedly treated with vehicle, ﬂu-
oxetine (20 mg/kg), nortriptyline (20 mg/kg) or mirtazapine (10 mg/kg).
Head dipping (s) Risk assessment (s)
Treatment Training Test Training Test
Vehicle 38.3±12.8 42.6±7.3 25.8±6.9 14.7±3.5
Fluoxetine 28.8±7.7 41.0±6.3 24.4±5.9 11.0±3.0
Nortriptyline 30.4±7.8 41.7±11.3 19.5±3.2 6.3±1.9
Mirtazapine 19.9±4.4 16.0±6.3 18.6±4.1 9.7±2.7
ANOVA did not reveal signiﬁcant effects of the treatment.
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creased percentage of time in the aversive arm when compared
with all other groups in this block.
3.2. Plus-maze discriminative avoidance task: anxiety
No signiﬁcant effects of treatment were found for the percentage
of time (Fig. 2A and B) or entries (Fig. 2C and D) into the open
arms, indicating the absence of effects on anxiety-related behavior.
Similarly, no differences were found in the time spent on head
dipping or in risk assessment behaviors (Table 1).
3.3. Plus-maze discriminative avoidance task: locomotion
ANOVA revealed an effect of treatment in the distance traveled
in the apparatus in the training [F(3,31)=4.56, pb0.01] and test
[F(3,31)=3.86, pb0.05] sessions. Post hoc analysis with Bonferroni's
test showed that the animals treated with mirtazapine exhibited
signiﬁcantly decreased locomotor activity compared with the other
groups in both sessions (Table 2).
3.4. Forced swimming test
ANOVA revealed an effect of treatment in immobility duration
[F(3,30)=13.64, pb0.001]. Post hoc analysis with Bonferroni's test
showed that the animals treated with ﬂuoxetine and mirtazapine
had decreased immobility duration compared with the control and
nortriptyline groups (Fig. 3A). Moreover, ANOVA revealed a treat-
ment effect on climbing behavior [F(3,30)=4.17, p=0.01]. Post-
hoc analysis with Bonferroni's test showed that the ﬂuoxetine group
had increased time spent in climbing behavior compared with the
nortriptyline group (Fig. 3B). The latency to start immobility was
not different among the groups (data not shown).
4. Discussion
In summary, our data showed that antidepressants can inﬂuence
learning processes and more speciﬁcally, the extinction of an aversive
task. Indeed, no treatment effects were observed in relation to the
acquisition or retrieval of the task. The extinction of the task was0
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treated with vehicle (vehi), 20 mg/kg ﬂuoxetine (ﬂuox), 20 mg/kg nortriptyline (nort) or 1evaluated by the progressive increase of the aversive arm exploration
during the test session when the aversive stimuli were no longer pre-
sent. During this session, vehicle and ﬂuoxetine groups (but not the
nortriptyline- or mirtazapine-treated animals) showed extinction of
the task, i.e., signiﬁcant increases in aversive arm exploration across
the session blocks. However, the data suggest that treatment with
ﬂuoxetine was capable of improving the process of extinction (see
Fig. 1D) because ﬂuoxetine-treated rats showed increased aversive
arm exploration earlier in the test/extinction session. Additionally,
speciﬁcally regarding the antidepressant effects on mood, the results
obtained in the FST showed that treatment with ﬂuoxetine and
mirtazapine reduced rat immobility time (see Fig. 3A), which is con-
sistent with previous studies (Carr et al., 2011; Cryan and Lucki, 2000;
Djordjevic et al., 2012; Dulawa et al., 2004; Iñiguez et al., 2010;
Miyamoto et al., 2010; Nowakowska et al., 1999; Rogóż, 2010;
Szymańska et al., 2009; Wang et al., 2011).
4.1. Extinction of the aversive task: ﬂuoxetine
As mentioned above, the analysis of the aversive arm exploration
throughout the test session of the PMDAT provides indication of
both task retrieval (beginning of session) and extinction (subsequent
session blocks) (Ribeiro et al., 2010). Indeed, with the aversive stimuli
no longer present, the animals avoid the aversive arm at ﬁrst but
eventually visit the arm, which would now be considered safe. Ani-
mals then progressively increase exploration of this arm, reaching
the amount they would explore a regular enclosed arm by chance
(or even more because this arm is mostly unfamiliar for them in the0
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Table 2
Mean±S.E. of distance traveled (m) by female rats repeatedly treated with vehicle, ﬂu-
oxetine (20 mg/kg), nortriptyline (20 mg/kg) or mirtazapine (10 mg/kg).
Treatment Training session Test session
Vehicle 19.0±2.4 21.1±1.9
Fluoxetine 20.0±3.0 21.6±4.4
Nortriptyline 22.9±3.1 16.8±4.4
Mirtazapine 10.4±0.5⁎ 8.5±2.3⁎
⁎ pb0.05 compared to all other groups (ANOVA followed by Bonferroni post hoc).
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previous study, we have shown that female rats kept avoiding the
aversive arm despite the absence of aversive stimuli (Ribeiro et al.,
2010). It has been suggested that this lack of extinction is similar
to what occurs in some anxiety disorders, such as posttraumatic
stress disorder (PTSD), and could be related to the greater prevalence
of mood and anxiety disorders in females (Bekker and van Mens-
Verhulst, 2007; Kendler et al., 2001; Mahendran and Yap, 2005;
Rauch et al., 2006).
The data presented here indicated that the SSRI ﬂuoxetine was
capable of increasing or accelerating the process of extinction in
females. Although speculative, one might hypothesize that the thera-
peutic action of ﬂuoxetine could be related to the extinction of
aversive memories. In line with this reasoning, this drug has shown
potential beneﬁts in the treatment of PTSD, which has a close rela-
tionship with deﬁcits in the extinction of traumatic memories (APA,
2000; Quirk et al., 2006; Yamamoto et al., 2008, 2009).
The SSRIs are among the most commonly prescribed drugs for
treating mood and anxiety disorders (Brunello et al., 2001; Marks
et al., 1998; Nandam et al., 2007). It has been suggested that one of
their effects is an improvement of possible cognitive deﬁcits related
to these disorders (Austin et al., 2001; Castaneda et al., 2008), partic-
ularly through the stimulation of neurogenesis (Dranovsky and Hen,
2006; Duman and Monteggia, 2006; Nandam et al., 2007; Paizanis
et al., 2007; Pittenger and Duman, 2008; Sahay and Hen, 2007). In
this respect, neurogenesis also plays a role in extinction processes
(Gabriele and Packard, 2006). Further, treatment with ﬂuoxetine0
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Fig. 3.Mean+S.E. for time (s) spent in immobility (A) and in climbing behavior (B) of
female rats repeatedly treated with vehicle (vehi), 20 mg/kg ﬂuoxetine (ﬂuox), 20 mg/
kg nortriptyline (nort) or 10 mg/kg mirtazapine (mirt) in the forced swimming test.
*pb0.05 compared to vehi; #pb0.05 compared to nort (ANOVA followed by Bonferroni
post hoc).also induces an increase in the release of brain-derived neurotrophic
factor (BDNF), which is related to mechanisms of neuronal plasticity
(Castrén and Rantamäki, 2010). In addition, another study has
shown that BDNF is necessary for memory extinction (Gabriele and
Packard, 2006). However, the role of BDNF in depression remains
unclear because antidepressant effects of nortriptyline and escitalo-
pram, for example, seem to be unrelated to hippocampal BDNF
expression in female rats (Hansson et al., 2011).
Relevant to the context of aversive memory extinction, previous
studies have demonstrated that antidepressants may induce synaptic
reorganization in the amygdala (McEwen and Chattarji, 2004). For
example, ﬂuoxetine chronically administered to adult rats reduces,
in the amygdala, the polysialylated form of the neural cell adhesion
molecule (PSA-NCAM), a molecule involved in synaptogenesis
(Homberg et al., 2011; Varea et al., 2007). These plasticity-related
mechanisms could underlie modiﬁcations of the experience of an
aversive event, which is in line with the results shown in the present
study. In summary, it seems plausible that the actions of antidepres-
sants could be related to a modulation of plastic processes related to
the extinction of aversive memories. Corroborating this hypothesis,
the animals treated with ﬂuoxetine showed decreased behavioral
despair (evaluated by the forced swimming test, see Fig. 3), con-
comitant with improvement in aversive memory extinction. Finally,
although these results seem relevant to understanding of the effects
of antidepressants, it is important to mention that the rats used in
this study were not submitted to any depression-inducing proce-
dures. Thus, it is clear that more studies are needed to investigate
the clinical relevance of these ﬁndings.4.2. Extinction of the aversive task: mirtazapine and nortriptyline
In the present study, neither the mirtazapine nor the nortriptyline
groups were able to extinguish the task. The nortriptyline-treated
animals also failed to respond in the FST, which is in line with the
assumption that alterations in extinction would play a role in the
antidepressant effects of the treatment. On the other hand, mirtaza-
pine treatment did induce an antidepressant effect in the FST (see
Fig. 3) despite the lack of extinction improvement.
Clinical studies with mirtazapine administered acutely show
decreased neural responses to fear and increased perception of
happy faces in healthy volunteers (Rawlings et al., 2010). On the
other hand, it has also been shown that mirtazapine decreases
the perception of both aversive and rewarding stimuli (Harmer
et al., 2006; McCabe et al., 2010). Nevertheless, there is a lack
of information concerning the effects of long-term mirtazapine
administration on emotional memory and/or upon confrontation
with aversive situations. In the present study, during the course
of the long-term mirtazapine treatment, the mood-related anti-
depressant effects could have appeared ﬁrst (inducing modiﬁca-
tions on the FST, see Fig. 3), while possible emotional memory
changes under aversive situations could have appeared afterwards
if a longer treatment period was used. Further studies are needed
to investigate this issue.
The hypolocomotor effects observed in females treated with
mirtazapine (see Table 2) have already been reported in a previous
study (Reneric et al., 2002). In the present study, the hypolocomotor
effects were speciﬁcally found in the PMDAT, i.e., they were not pre-
sent in the FST. It is known that mirtazapine enhances both 5-HT and
NA neurotransmissions, but differently from monoamine reuptake
inhibitors, its antidepressant effects are mediated through the direct
antagonism of both α2 and 5-HT2C receptors (de Boer et al., 1996;
Haddjeri et al., 1996). In addition, mirtazapine also induces blockage
of histamine-H1 receptors, which is another possible mechanism
that may produce sedation and decrease the exploratory activity
(Gambi et al., 2005; Schüle et al., 2003, 2006).
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Despite the fact that all drugs used in the present study are
clinically effective antidepressants, they show differences in their
mechanisms of action (see Introduction). Regarding target neuro-
transmitter systems of the three drugs, while ﬂuoxetine is a selective
serotonin reuptake inhibitor, both mirtazapine and nortriptyline have
mechanisms of action related to the noradrenergic function. In this
respect, it has been shown that noradrenergic activation impairs
extinction learning (Soeter and Kindt, 2011), although other results
have not corroborated this ﬁnding (Beralu and McGaugh, 2006).
From another standpoint, the differences in the mechanisms of
action could lead to diverse effects not directly related to the antide-
pressant action per se. These effects could explain why only ﬂuoxetine
was effective in modifying extinction of the aversive task. It has been
shown that mirtazapine and nortriptyline decrease hypothalamic–
pituitary–adrenal (HPA) axis activity (Schüle et al., 2002; 2006). In
this respect, an increase in HPA axis activity could impair the extinction
of an inhibitory avoidance task (Cassol-Jr et al., 2010), which is opposite
to the results obtained here. On the other hand, it is known that the
higher the sensitivity to cortisol, the higher the amygdala response to
stressful events (Morgan and LeDoux, 1995) and the lower the activa-
tion of hippocampus and prefrontal cortex (Lebrón et al., 2004).
Due to the role of these brain regions on aversive memory extinction
(Lebrón et al., 2004; Morgan and LeDoux, 1995; Quirk et al., 2006),
these effects could explain the decreased extinction shown by the
mirtazapine- and nortriptyline-treated animals when compared with
controls. In particular, studies in our laboratory have shown that
pharmacological manipulations within the amygdala modify extinction
of the PMDAT (Ferreira et al., unpublished results).
4.4. Anxiety-related behavior
Usually, clinical treatment with antidepressants has an overall an-
xiolytic effect, although it can possibly induce an increase in anxiety
at the beginning of treatment (for a review, see Borsini et al., 2002;
Drapier et al., 2007). Animal studies have also shown that antidepres-
sants can have anxiolytic effects when given acutely (Drapier et al.,
2007; Holmes and Rodgers, 2003; Kurt et al., 2000; Silva et al.,
1999). Herein, the treatment with antidepressants did not modify
the anxiety-related behaviors in any of the parameters evaluated
(see Fig. 2 and Table 1). To our knowledge, there have been few stud-
ies evaluating the effects of chronic treatment with nortriptyline in
behavioral tests related to anxiety. For example, Brocco et al. (2002)
showed that mice exposed to a novel environment failed to elevate
locomotion, suggesting the absence of an anxiolytic effect. Converse-
ly, the effects of chronic ﬂuoxetine treatment on anxiety have been
previously investigated, with some studies demonstrating anxiolytic
(Griebel et al., 1995; Mirza et al., 2007) and others showing anxio-
genic effects (File et al., 1999; Robert et al., 2011). In summary, it
seems that the effects of antidepressants on animal models of anxiety
are still controversial.
From another standpoint, despite most anxiety and mood
disorders occurring twice as frequently in women (Bekker and van
Mens-Verhulst, 2007), there is a strong bias towards the use of male
animals in studying these phenotypes (Wald and Wu, 2010; Zucker
and Beery, 2010). Indeed, most of the commonly used behavioral
apparatuses were developed using male rats, including the PMDAT
(Silva and Frussa-Filho, 2000). Although a previous study using this
task did not show differences in open-arm exploration between
untreated males and females (Ribeiro et al., 2010), studies using the
conventional version of the plus-maze (from which the apparatus
used here was adapted) have shown a difference in the minimal
effective dose of the classical anxiolytic diazepam between male
and female rodents (Basso et al., 2011; Nishino et al., 2008; Rodgers
and Shepherd, 1993). Although speculative, this ﬁnding mightsuggest that females could differentially interpret and, more impor-
tantly, react differently when exposed to the assumed anxiety-
evaluating situation in the plus-maze (i.e., the conﬂict between moti-
vation to explore and fear of the open spaces). In this respect, it has
been shown that female rats show different behavioral and hormonal
reactions to both natural and laboratory aversive situations when
compared with males (Astur et al., 2004; Perrot-Sinal et al., 2004;
Ribeiro et al., 2010; Taylor et al., 2000).
4.5. Forced swimming test
The forced swimming test is usually applied in the screening of
antidepressant drugs. In this test, immobility duration is believed to
measure the levels of “behavioral despair” (Borsini and Meli, 1988).
Moreover, the immobility presented by the animal is reversed by
repeated antidepressant treatment, and for this reason, it is used
as an index of a “depressive-like” state (Cryan et al., 2005; Porsolt
et al., 1978). In the present study, the animals treated with ﬂuoxetine
and mirtazapine showed decreased immobility duration in the FST, as
expected. However, rats treated with nortriptyline at a dose that was
previously shown to be effective when administered acutely did not
exhibit this decrease (Consoni et al., 2006). These rats also showed
less climbing behavior than the ﬂuoxetine-treated animals, suggest-
ing that the nortriptyline group was less active in this behavioral
test. However, the possibility that these effects were due to alter-
ations in locomotion seems unlikely because in the PMDAT, there
were no signiﬁcant decreases in ambulation of the nortriptyline-
treated animals.
5. Conclusion
Data reported in the present study showed that treatment with
three antidepressant drugs differentially modiﬁed extinction of an
aversive task in female rats. The modiﬁcations on memory extinction
induced by antidepressants do not seem to be related to their effects
on the FST, a classical test for mood-related antidepressant action.
These data contribute to the understanding of the behavioral effects
of antidepressant therapy, especially concerning the cognitive aspects
of the treatment.
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